27th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress

October 13-16, 2026

Hybrid Onsite Conference & Internet Event — Live and Archived
Washington Hilton
Washington, DC

Follow Pharma Congress on:  


Gregory T. Garcia

Executive Director, Cybersecurity Working Group, Health Sector Coordinating Council; Former Assistant Secretary for Cybersecurity, US DHS, Washington, DC

Gejaa T. Gobena, JD

Partner, Hogan Lovells Cadwalader; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Sarah M. Hall, JD

Partner, Member of the Firm, Epstein Becker Green; Former Trial Attorney, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

John Kelly, JD

Partner & Chair, Healthcare Practice, Barnes & Thornburg; Former Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC

Barbara A. Leaf, JD

Senior International Policy Advisor, Arnold & Porter; Former Special Assistant to the President; Former US Ambassador, UAE, Washington, DC

Christine Moundas, JD, MPH

Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Former Analyst, Office of Inspector General, US HHS, New York, NY

Kenneth A. Polite, Jr, JD

Partner & Global Co-leader, White Collar Defense, Sidley Austin LLP; Former Assistant Attorney General, Criminal Division, US DOJ, Washington, DC

David J. Scott, MS

Managing Director, Forensic & Integrity Services, EY; Former Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA

Diane Seol, JD

Of Counsel, Choate Hall & Stewart; Former Assistant United States Attorney, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA

Michael L. Shaw, JD

Global Head of Compliance, Privacy and Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, OIG US HHS, Princeton, NJ

Amanda Strachan, JD

Partner, WilmerHale; Former AUSA & Chief, Criminal Division, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA

Jane H. Yoon, JD

Partner, Litigation Department, Paul Hastings; Former Assistant United States Attorney, US Attorney’s Office, New Jersey, New York, NY


COMPLIANCE EXPERTS, ADVISORS AND COUNSEL

David Amendola

Director, Life Sciences, Resolution Economics; Former Global Compliance, ConvaTec, New York, NY

Eliza L. Andonova, JD

Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC

Minna Bak, MBA

Director, HELIO, Boston, MA

Brett Barlag, MBA

Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY

Samantha Barrett Badlam, JD

Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

Yogesh Bahl, MBA

Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY

David M. Blank, JD

Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC

Craig B. Bleifer, JD

Partner, McGuire Woods; Former Corporate VP, GC North America; Novo Nordisk, New York, NY

Brian A. Bohnenkamp, MHA, JD

Partner, FDA and Life Sciences, King & Spalding, Washington, DC

Eric Bolesh

Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

Mary Capizzi, JD, MBA

Partner, Faegre Drinker; General Counsel, International Pharmaceutical & Medical Device Privacy Consortium, Washington, DC

Jennifer Ceglinski, JD, CFE

Manager, Forensic & Integrity Services, EY, Charlotte, NC

Matthew Chandler, JD

Director, Epsilon Life Sciences, Richmond, VA

Michael Clarke, JD, CCEP, NACD.DC®

Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec, Bridgewater, NJ

Chris Cobourn, MS

Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL

Benjamin Correa, JD

Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC

Zachary Coseglia, JD

Co-Founder, Culture. Data. Ethics; Former VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA

Layla Covington, JD

Senior Manager, Compliance Consulting, Cresen; Former Manager, Aggregate Spend, Genentech, Chicago, IL

Clarissa Crain

Managing Director, Deloitte, Phoenixville, PA

Kari Czeszewski, CHC

Associate, Epsilon Life Sciences, New York, NY

Jamie E. Darch, JD

Partner, HIPAA and State Data Privacy & Cybersecurity Law, Ropes & Gray, Chicago, IL

Meena Datta, JD

Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL

Mahnu V. Davar, MA, JD

Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

Edward Diskant, JD

Partner, McDermott Will & Schulte; Former AUSA, Southern District of New York, US DOJ, New York, NY

Stefanie A. Doebler, JD

Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC

Joy Dowdle, JD

Partner, Litigation Department, Paul Hastings and Co-Chair of the Houston Office, Houston, TX

Kip Ebel, MBA

Principal, Forensic & Integrity Services, EY, New York, NY

Aurelie Ercoli, LLM, PhD

Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC

Ronnie H. Feldman

Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL

Alison J. Fethke, JD

Member, Epstein Becker Green; Former Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL

David Fisher, MS

President, TDI Solutions; Former VP & General Manager, Cyber Innovations, Battelle, Washington, DC

Sara K. Frank, JD

Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA

Gary F. Giampetruzzi, JD

Partner & Global Chair Life Sciences, Paul Hastings; Former VP & AGC, Head of Government Investigations, Pfizer, New York, NY

John Gitas, MBA

Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY

Noah C. Goldstein, JD

Counsel, Pharma, Biotech & Medical Device Legal, Regulatory, & Compliance, Porzio Bromberg & Newman, Westborough, MA

Anthony Greco, MBA

Managing Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA

Asha Green, JD, MPA

Director, US Compliance, Ferring; Former Global Head, I&C Risk Assessment & Senior Business Advisor, Indivior, Parsippany, NJ

Neeraj Gupta, MBA

President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA

Kris Hall, JD, CIPP/CIPM

Managing Director, Dovetail; Former VP, Chief Privacy Officer, Celgene; Former VP, Head of Privacy, Shire, Bridgton, ME

Kristin M. Hicks, JD

Partner, Arnold & Porter, Washington, DC

Emily F. Hodge, JD

Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA

Casey J. Horton, CFE

Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL

Jeff Hyre

Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO

Katie Jacyna

Vice President, Product Management, Helio Health Group, Denver, CO

Mark A. Jensen, JD

Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC

Erin Brown Jones, MA, JD

Partner, Latham & Watkins, Washington, DC

Marci Juneau, MBA

A Founding Partner, Helio Health Group, Atlanta, GA

Kristin Graham Koehler, JD

Managing Partner, DC Office & Executive Committee Member, Sidley Austin, Washington, DC

Olivia Krzeminski, JD

Director of Compliance & Legal Research, G&M Health, Somerset, NJ

Rebekah Latchis, JD

VP, Global Investigations, Data & Governance, Medtronic; Former Corporate Responsibility Director, Bon Secours, Washington, DC

Stephanie Lewko, CFE

Managing Director, Ankura, Washington, DC

Jeffrey Low, RPh, MHA

Director, Ankura; Former VP, Clinical Services, Magellan Health; Former Director, Medicare Services, CVS/Caremark, Phoenix, AZ

Robert Melillo, JD

Co-founder and Managing Director, G&M Health, Cocoa Beach, FL

Brook Mishler, RN, MSN

Global Director of Compliance Solutions, Life Sciences, Case IQ; Former Compliance Officer for the Americas, Cordis, Ontario, Canada

Tracy Mumpower

Director, Life Science Revenue, Government Pricing, HELIO; Fmr Manager, Commercial Contract Admin, King, Bristol, VA

Katherine C. Norris, MPA

Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI

Daniel O’Connor

Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ

Michael T. O’Connor

Chief Executive Officer, Qordata; Angel Investor, Angel Investor Forum, New York, NY

John Poulin

Chief Technology Officer and Partner, Helio Health Group, Boston, MA

Adam T. Oakley

Senior Director, Potomac River Partners, Washington, DC

Saraswatha Lalitha Putcha, MA

Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA

John S. Rah, JD

Counsel and Head, Life Sciences Compliance Practice, Potter & Murdock, Potomac, MD

Nikki Reeves, JD

Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

Michael Reyes

Director, Risk & Regulatory Consulting, PwC; Former Analyst, Compliance Analytics, Edwards Lifesciences, Dallas, TX

Brian Riewerts, MPA

Partner, Pharmaceutical and Life Sciences Risk and Regulatory Leader, PwC, Washington, DC

Russell Rose, JD

Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX

Russell Schaefer, MBA

Managing Director, BCG, Washington, DC

Jeffrey Scott, JD

Of Counsel, DLA Piper; Former Lead Compliance Counsel Digital, Pfizer, Philadelphia, PA

Kala Shankle, JD

VP, Regulatory, Healthcare Distribution Alliance; President Elect, American Society Pharmacy Law, Wash., DC

Paul Silver

Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA

Emily (Jaffe) Singh

Partner, Global Spend Transparency Practice Leader, PwC, Chicago, IL

Laura A. Skinner, MBA

Managing Director, Life Sciences Consulting, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY

Ravneet Talwar, MBA

Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY

Stephanie Trunk, JD

Partner, Life Science Practice Group, Arent Fox Schiff; Former Legal Counsel, Catalyst Health Solutions, Washington, DC

Brian Van Hoy, RPh

Vice President of Compliance, G&M Health; Former Director Compliance & Ethics, Eli Lilly, Somerset, NJ

L. Stephan Vincze, JD, LLM, MBA

President & CEO, TRESTLE Compliance; Former SVP & CCO, Warner Chilcot; Former VP & CCO, TAP, Boston, MA

Erin Wagenberg, CIPP/US, CIPP/E, CIPT

Director, Dovetail Consulting Group; Former Deputy Privacy Officer, Deloitte Global, Atlanta, GA

Shannon Walker

Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada

Robert A. Wells, JD

Shareholder & Chair, Health Law and Government Solutions, Baker, Donelson, Bearman, Caldwell & Berkowitz, Baltimore, MD

Sarah L. Whipple, JD

Principal, WhipEdge Solutions; Member, Rare Disease Compliance Consortium; Former VP, GCCO, Apellis, Needham, MA

Kelly Willenberg, MBA, DBA, CHC

Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC

Jacob Wolf, MBA

Chief Commercial Officer, Cresen Solutions, Orlando, FL

Heather Young, JD

Senior Director, Compliance Officer, Global Business Partner, Olympus; Former Philadelphia Assistant DA, Center Valley, PA

Cobun Zweifel-Keegan, JD

Managing Director, IAPP; Former Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC

THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.


AN OVERVIEW OF THE 27TH CONGRESS SCHEDULE

Day 1: Tuesday, October 13, 2026

  • Afternoon Half-day Specialty Focused Sessions
  • Day 2: Wednesday, October 14, 2026

  • Networking Breakfast

  • Morning Concurrent Mini Summits

  • Networking Luncheon

  • Afternoon Opening Plenary Session

  • Networking Reception
  • Day 3: Thursday, October 15, 2026

  • Networking Breakfast

  • Morning PCF CCO Roundtable (Invitation-only)

  • Morning Concurrent Mini Summits

  • Networking Luncheon

  • Afternoon Closing Plenary Session
  • Day 4: Friday, October 16, 2026

  • Networking Breakfast

  • Morning PCF Industry-only Plenary Session

  • Noon: Congress Adjournment

  • AND REMEMBER THAT ALL ATTENDEES HAVE COMPLIMENTARY ACCESS TO THE CONGRESS VIRTUAL VIDEO ARCHIVE FOR 9 MONTHS FOLLOWING THE EVENT


    FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL

    Featuring one-on-one attendee video chat and large group video interactive workshops.
    See last year’s Congress portal:

    A HYBRID CONFERENCE AND INTERNET EVENT